Long-term storage in liquid nitrogen does not affect cell viability in cardiac valve allografts

Cryobiology

Volumn 57, Issue 2, 2008, Pages 113-121

  Mirabet, V ^a   Carda, C ^b   Solves, P ^a   Novella Maestre, E ^b   Carbonell Uberos, F ^a   Caffarena, J M ^c   Hornero, F ^d   Montero, J A ^c   Roig, R J ^a  

^a Banco de Tejidos   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Cryoinjury; Cryopreservation; Heart valves; Length of storage; Liquid nitrogen; Viability

Indexed keywords

AMPHOTERICIN B; CD31 ANTIGEN; COTRIMOXAZOLE; DACTINOMYCIN; GLUCOSE; HUMAN SERUM ALBUMIN; LIQUID NITROGEN; MONOCLONAL ANTIBODY; THY 1 ANTIGEN; TOBRAMYCIN; VANCOMYCIN;

ADOLESCENT; ADULT; ALLOGRAFT; ANTIGEN EXPRESSION; AORTA VALVE; ARTICLE; CELL CULTURE; CELL VIABILITY; CHILD; CONFOCAL LASER MICROSCOPY; CRYOPRESERVATION; ELECTRON MICROSCOPY; EXPLANT; FEMALE; FLOW CYTOMETRY; HEART TRANSPLANTATION; HEART VALVE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MICROSCOPY; ORGAN DONOR; PRIORITY JOURNAL; PULMONARY VALVE; TISSUE PRESERVATION;

ADOLESCENT; ADULT; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CHILD; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; FEMALE; FLOW CYTOMETRY; HEART VALVES; HUMANS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; NITROGEN; SERUM ALBUMIN; TIME FACTORS; TISSUE PRESERVATION; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 52149090108     PISSN: 00112240     EISSN: 10902392     Source Type: Journal    
DOI: 10.1016/j.cryobiol.2008.07.008     Document Type: Article

References (33)

1. Armiger L.C. Viability studies of human valves prepared for use as allografts. Ann. Thorac. Surg. 60 2 Suppl. (1995) 118-121
2. Bechtel J.F.M., Bartels C., Schmidtke C., Skibba W., Müller-Steinhardt M., Klüter H., et al. Does histocompatibility affect homograft valve function after the Ross procedure?. Circulation 104 Suppl. 1 (2001) 25-28
3. Boyer M., Townsend L.E., Vogel L.M., Falk J., Reitz-Vick D., Trevor K.T., et al. Isolation of endothelial cells and their progenitor cells from human peripheral blood. J. Vasc. Surg. 31 1 Pt 1 (2000) 181-189
4. Dainese L., Barili F., Topkara V.K., Cheema F.H., Formato M., Aljaber E., et al. Effect of cryopreservation techniques on aortic valve glycosaminoglycans. Artif. Organs 30 4 (2006) 259-264
5. den Hamer I., Hepkema B., Prop J., Elzenga N., and Ebels T. HLA antibodies specific for cryopreserved heart valve "homografts" in children. Thorac. Cardiovasc. Surg. 113 2 (1997) 417-419
6. Fahy G.M. The relevance of cryoprotectant "toxicity" to cryobiology. Cryobiology 23 1 (1986) 1-13
7. Feng X.J., van Hove C.E., Mohan R., Walter P.J., and Herman A.G. Effects of different antibiotics on the endothelium of the porcine aortic valve. J. Heart Valve Dis. 2 6 (1993) 694-704
8. Fischlein T., Schütz A., Uhlig A., Frey R., Krupa W., Babic R., et al. Integrity and viability of homograft valves. Eur. J. Cardiothorac. Surg. 8 8 (1994) 425-430
9. Gall K., Smith S., Willmette C., Wong M., and OBrien M. Allograft heart valve sterilization: a six-year in-depth analysis of a twenty-five-year experience with low-dose antibiotics. Thorac. Cardiovasc. Surg. 110 3 (1995) 680-687
10. Gall K.L., Smith S.E., Willmette C.A., and O'Brien M.F. Allograft heart valve viability and valve-processing variables. Ann. Thorac. Surg. 65 4 (1998) 1032-1038
11. Galmes A., Besalduch J., Bargay J., Novo A., Morey M., Guerra J.M., et al. Long-term storage at -80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant. Transfusion 39 1 (1999) 70-73
12. Hawkins J.A., Hillman N.D., Lambert L.M., Jones J., Di Russo G.B., Profaizer T., et al. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts. J. Thorac. Cardiovasc. Surg. 126 1 (2003) 247-252
13. Hogan P., Duplock L., Green M., Smith S., Gall K.L., Frazer I.H., et al. Human aortic valve allografts elicit a donor-specific immune response. J. Thorac. Cardiovasc. Surg. 112 5 (1996) 1260-1267
14. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24 2 (2004) 288-293
15. Jashari R., Daenen W., Meyns B., and Vanderkelen A. Is ABO group incompatibility really the reason of accelerated failure of cryopreserved allografts in very young patients? Echography assessment of the European Homograft Bank (EHB) cryopreserved allografts used for reconstruction of the right ventricular outflow tract. Cell Tissue Bank. 5 4 (2004) 253-259
16. Kadner C., Chen R.H., and Mitchell R.N. Lack of ABH-antigen expression on human cardiac valves. J. Heart Valve Dis. 9 4 (2000) 512-516
17. Kasimir M.T., Rieder E., Seebacher G., Nigisch A., Dekan B., Wolner E., et al. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J. Heart Valve Dis. 15 2 (2006) 278-286
18. Ketheesan N., Kearney J.N., and Ingham E. The effect of cryopreservation on the immunogenicity of allogeneic cardiac valves. Cryobiology 33 1 (1996) 41-53
19. Messier Jr. R.H., Domkowski P.W., Aly H.M., Jones J.L., Hilbert S.L., Crescenzo D.G., et al. Adenine nucleotide depletion in cryopreserved human cardiac valves: the "stunned" leaflet interstitial cell population. Cryobiology 32 3 (1995) 199-208
20. Mirabet V., Bonanad S., Blasco I., Planelles M.D., de la Concepción M., Ródenas T., et al. Fractures in cryopreserved aortic and pulmonary valve grafts. Cryobiology 35 4 (1997) 381-382 Ref Type: Abstract
21. Mirabet V., Bonanad S., Soler M.A., Gómez-Ullate J.M., Caffarena J.M., de la Concepción M., et al. Fractures in cryopreserved aortic and pulmonary valved condults. Cir. Cardiov. 6 1 (1999) 54-59
22. Mitchell R.N., Jonas R.A., and Schoen F.J. Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J. Thorac. Cardiovasc. Surg. 115 1 (1998) 118-127
23. O'Brien M.F., Stafford E.G., Gardner M.A., Pohlner P.G., and McGiffin D.C. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J. Thorac. Cardiovasc. Surg. 94 6 (1987) 812-823
24. Ohkado A., Hachida M., Furukawa H., Lu H., Hanayama N., Hoshi H., et al. Should the aortic valve homograft be recryopreserved?. Ann. Thorac. Surg. 65 4 (1998) 1083-1086
25. Pasquinelli G., Tazzari P.L., Vaselli C., Foroni L., Buzzi M., Storci G., et al. Thoracic aortas from multiorgan donors are suitable for obtaining resident angiogenic mesenchymal stromal cells. Stem Cells 25 7 (2007) 1627-1634
26. Rajani B., Mee R.B., and Ratliff N.B. Evidence for rejection of homograft cardiac valves in infants. J. Thorac. Cardiovasc. Surg. 115 1 (1998) 111-117
27. Shaddy R.E., Tani L.Y., Sturtevant J.E., Lambert L.M., and McGough E.C. Effects of homograft blood type and anatomic type on stenosis, regurgitation and calcium in homografts in the pulmonary position. Am. J. Cardiol. 70 3 (1992) 392-393
28. Stark J., Bull C., Stajevic M., Jothi M., Elliott M., and de Leval M. Fate of subpulmonary conduits: determinants of late homograft failure. J. Thorac. Cardiovasc. Surg. 115 3 (1998) 506-516
29. Verghese S., Padmaja P., Sindhu B., Elizabeth S.J., Lesley N., and Cherian K.M. Homograft valve banking: our experience in valve banking. Indian Heart J. 56 4 (2004) 299-306
30. Villalba R., Peña J., Luque E., and Gómez Villagrán J.L. Characterization of ultrastructural damage of valves cryopreserved under standard conditions. Cryobiology 43 1 (2001) 81-84
31. Walters H.L., Lobdell K.W., Tantengco V., Lyons J.M., Hudson C.L., Struble S.L., et al. The Ross procedure in children and young adults with congenital aortic valve disease. J. Heart Valve Dis. 6 4 (1997) 335-342
32. Yacoub M., Rasmi N.R., Sundt T.M., Lund O., Boyland E., Radley-Smith R., et al. Fourteen-year experience with homovital homografts for aortic valve replacement. J. Thorac. Cardiovasc. Surg. 110 1 (1995) 186-193
33. Zengin E., Chalajour F., Gehling U.M., Ito W.D., Treede H., Lauke H., et al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133 8 (2006) 1543-1551